Behcet's Disease

24 registered clinical trials studyying Behcet's Disease — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases NCT06285539	UMC Utrecht	Phase 2
Recruiting	Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266	Sanguine Biosciences	—
Completed	Low-dose IL-2 Treatment on Behcet's Disease NCT04065672	HeJing	Phase 2
Completed	Behçet and LDH/Albumin NCT06276829	Ataturk University	—
Unknown	Anti IL-18 (GSK1070806) in Behcet's Disease NCT03522662	Cambridge University Hospitals NHS Foundation Trust	Phase 2
Completed	Evaluation of Fibromyalgia With Disease Activity and Clinical Findings in Women With Behçet's Disease NCT03543709	Bursa Yuksek Ihtisas Training and Research Hospital	—
Completed	Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease NCT03371095	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Dis NCT03531385	Bursa Yuksek Ihtisas Training and Research Hospital	—
Completed	Journey of Patients With Vasculitis From First Symptom to Diagnosis NCT03410290	University of Pennsylvania	—
Recruiting	Vasculitis Pregnancy Registry NCT02593565	University of Pennsylvania	—
Completed	Impact of Vasculitis on Employment and Income NCT02476292	University of South Florida	—
Completed	VCRC Patient Contact Registry Patient-Reported Data Validation Study NCT02190942	University of South Florida	—
Completed	Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases NCT01988506	Assistance Publique - Hôpitaux de Paris	Phase 2
Unknown	Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases NCT01952275	University of Zurich	—
Completed	Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation) NCT01960790	AbbVie	—
Completed	Educational Needs of Patients With Systemic Vasculitis NCT02190929	University of South Florida	—
Completed	Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions NCT01532570	Tanabe Pharma Corporation	Phase 3
Completed	Vasculitis Illness Perception (VIP) Study NCT02190916	University of South Florida	—
Completed	Reproductive Health in Men and Women With Vasculitis NCT02176070	University of South Florida	—
Withdrawn	A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Dise NCT01211977	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Phase 1 / Phase 2
Completed	The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease NCT04328064	University of Alexandria	N/A
Terminated	Immunogenetic Mechanisms in Behcet's Disease NCT01109433	National Eye Institute (NEI)	—
Unknown	The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease NCT01306955	Tehran University of Medical Sciences	Phase 4
Completed	Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) NCT00167583	University Hospital Tuebingen	Phase 3